Has Valerie Mbacke received payments from drug or device companies?

Yes. Drug and device makers reported $2,296 in general payments to Valerie Mbacke across 86 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Valerie Mbacke did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Valerie Mbacke come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Valerie Mbacke

Family · Cincinnati, OHNPI 1013387679

Payments from drug & device makers

$2,296in general payments, 2019–2025

Across 86 payments — averaging $26.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$632
AstraZeneca$322
Bayer$276
Gen-probe Sales & Service, Inc.$164
Exact Sciences$138
Biohaven Pharmaceuticals, Inc.$118
plus $646 from 19 others

What the payments were for

Food & beverage$2,296100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	33	$632
AstraZeneca	8	$322
Bayer	2	$276
Gen-probe Sales & Service, Inc.	2	$164
Exact Sciences	6	$138
Biohaven Pharmaceuticals, Inc.	1	$118
Gilead	4	$79
Merck	3	$59
Hologic Sales And Service, LLC	2	$59
Supernus Pharmaceuticals, Inc.	3	$50
Pfizer	3	$50
Axsome Therapeutics, Inc.	2	$46
Exeltis, USA Inc.	2	$37
GSK	2	$36
Indivior Inc.	2	$31
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$30
Alkermes, Inc.	1	$30
Neurelis, Inc.	1	$21
VBI Vaccine (delaware) Inc.	1	$20
Cranial Technologies, Inc	1	$19
Novo Nordisk	1	$19
Seqirus USA Inc	1	$17
Takeda Pharmaceuticals U.S.A., Inc.	1	$17
Lilly USA, LLC	1	$13
Amneal Pharmaceuticals LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,296 in reported general payments places this provider in the 85th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
FarxigaDapagliflozin Propanediol	14	$17,622
Spiriva RespimatTiotropium Bromide	23	$14,723
JardianceEmpagliflozin	14	$13,683
JanuviaSitagliptin Phosphate	12	$6,756
Aripiprazole	26	$5,250
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	13	$1,923
Albuterol Sulfate HfaAlbuterol Sulfate	64	$1,631
Carbamazepine ErCarbamazepine	13	$1,571
Sertraline Hcl	40	$600
Atorvastatin Calcium	84	$408
Diclofenac Sodium	12	$361
Montelukast Sodium	26	$337
Levothyroxine Sodium	36	$313
Lisinopril	40	$302
Omeprazole	31	$298

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AstraZenecaFarxiga	$322	$17,62214 claims
MerckJanuvia	$59	$6,75612 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium	$13	$31336 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,812 family providers in Ohio.

Other family in Cincinnati

George KnightCincinnati$130K
Jillian HuntCincinnati$116K
Lindsey SpencerCincinnati$53K
Bria BarjucaCincinnati$38K
Jillian CowanCincinnati$20K
Eileen FauldsLewis Center$991K
Leigh Ann PanschDayton$670K
Natalie BelliniMayfield Heights$582K
Kaitlyn LovettMontgomery$286K
Amy RossDayton$281K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →